Bad Influence: EWS/FLI Alters LSD1 and NuRD Interactions to Enforce Oncogenic Function in Ewing’s |
Research Institute at Nationwide Children's Hospital / Emily Theisen, PhD |
Young Investigator Grants |
2016 |
Ohio |
Pre-clinical Evaluation of LSD1 Inhibitors for the Treatment of Pediatric Ewing sarcoma: Defining the Biomarkers of Sensitivity and Mechanisms of Resistance |
Research Institute at Nationwide Children's Hospital / Kathleen Pishas, PhD |
Young Investigator Grants |
2016 |
Ohio |
Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma |
University of Pennsylvania / Nicole Anderson, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2016 |
Pennsylvania |
Sepsis as innate immune stimulus: severe sepsis exposures and protection against relapse in children with acute leukemias |
Children’s Hospital of Philadelphia / Alix Seif, MD |
Epidemiology Grants |
2016 |
Pennsylvania |
Micro-environmental Regulators of Ewing sarcoma Metastasis |
University of Pittsburgh / Kelly Bailey, MD/PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
DFMO Synergy with Chemo-immunotherapy to Eradicate MYC-Driven Neuroblastoma |
Children’s Hospital of Philadelphia / Michael Hogarty, MD |
Reach Grants |
2016 |
Pennsylvania |
Variation in Care and Outcomes in Pediatric Acute Leukemia |
Children’s Hospital of Philadelphia / Amanda DiNofia, MD |
Young Investigator Grants |
2016 |
Pennsylvania |
GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma |
Children’s Hospital of Philadelphia / Kristopher Bosse, MD |
Young Investigator Grants |
2016 |
Pennsylvania |
CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL |
Children’s Hospital of Philadelphia / Asen Bagashev, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |